For: | Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. World J Gastroenterol 2015; 21(21): 6649-6659 [PMID: 26074703 DOI: 10.3748/wjg.v21.i21.6649] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i21/6649.htm |
Number | Citing Articles |
1 |
Cem Cengiz, Safak Bulut, A. Sedat Boyacioglu, M. Ayhan Kuzu. Nerve/Glial Antigen 2: A Novel Target for Anti-Tumor Therapy in Colorectal Cancer. Digestion 2017; 96(1): 60 doi: 10.1159/000478853
|
2 |
Joana G. Rodrigues, Meritxell Balmaña, Joana A. Macedo, Juliana Poças, Ângela Fernandes, Julio Cesar M. de-Freitas-Junior, Salomé S. Pinho, Joana Gomes, Ana Magalhães, Catarina Gomes, Stefan Mereiter, Celso A. Reis. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis. Cellular Immunology 2018; 333: 46 doi: 10.1016/j.cellimm.2018.03.007
|
3 |
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, Audrey Monneur, Maria Abbondanza Pantaleo, Annalisa Astolfi, Jerzy Ostrowski, Daniel Birnbaum, Emilie Mamessier, François Bertucci. CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers 2022; 14(5): 1306 doi: 10.3390/cancers14051306
|
4 |
Le Yang, Hang Zhang, Chengbin Dong, Wenhui Yue, Renmin Xue, Fuquan Liu, Lin Yang, Liying Li. Neuron-Glial Antigen 2 Participates in Liver Fibrosis via Regulating the Differentiation of Bone Marrow Mesenchymal Stem Cell to Myofibroblast. International Journal of Molecular Sciences 2023; 24(2): 1177 doi: 10.3390/ijms24021177
|
5 |
Alexandra Y Tsidulko, Galina M Kazanskaya, Diana V Kostromskaya, Svetlana V Aidagulova, Roman S Kiselev, Alexandr M Volkov, Vyacheslav V Kobozev, Alexei S Gaitan, Alexei L Krivoshapkin, Elvira V Grigorieva. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma. Tumor Biology 2017; 39(9): 101042831772428 doi: 10.1177/1010428317724282
|
6 |
Zoi Piperigkou, Benedikt Mohr, Nikos Karamanos, Martin Götte. Shed proteoglycans in tumor stroma. Cell and Tissue Research 2016; 365(3): 643 doi: 10.1007/s00441-016-2452-4
|
7 |
Hongyu Zhang, Zhenyu Wu, Deyu Hu, Min Yan, Jing Sun, Jiejuan Lai, Lianhua Bai. Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ Cancers. Vaccines 2022; 10(7): 1023 doi: 10.3390/vaccines10071023
|
8 |
Laurys Boudin, A de Nonneville, Pascal Finetti, Léna Mescam, A Le Cesne, Antoine Italiano, Jean-Yves Blay, Daniel Birnbaum, Emilie Mamessier, François Bertucci. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03679-y
|
9 |
Tomohiro KUROKAWA, Kohzoh IMAI. Chondroitin sulfate proteoglycan 4: An attractive target for antibody-based immunotherapy. Proceedings of the Japan Academy, Series B 2024; 100(5): 293 doi: 10.2183/pjab.100.019
|
10 |
May-Britt Firnau, Angela Brieger. CK2 and the Hallmarks of Cancer. Biomedicines 2022; 10(8): 1987 doi: 10.3390/biomedicines10081987
|
11 |
Ruhi Gulati, Maggie Lutz, Margaret Hanlon, Ashley Cast, Rebekah Karns, James Geller, Alex Bondoc, Gregory Tiao, Lubov Timchenko, Nikolai A. Timchenko. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma. Hepatology Communications 2024; 8(2) doi: 10.1097/HC9.0000000000000369
|
12 |
Georgios-Ioannis Verras, Levan Tchabashvili, David-Dimitris Chlorogiannis, Francesk Mulita, Maria-Ioanna Argentou. Updated Clinical Evidence on the Role of Adipokines and Breast Cancer: A Review. Cancers 2023; 15(5): 1572 doi: 10.3390/cancers15051572
|